title: Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression.
abstract: To evaluate the role of cellular activation markers and functional surface molecules in sepsis, specific immunophenotypes on peripheral blood leukocytes were studied in 40 subjects consisting of the following: (1) patients with septic shock; (2) patients with sepsis; (3) critically ill nonseptic patients; and (4) normal control subjects. These assays included phagocyte adhesion molecule CD11b expression, monocyte receptors HLA-DR and CD14, and lymphocyte activation markers IL-2R and HLA-DR. Patients with septic shock and sepsis had significantly increased neutrophil CD11b expression compared with normal subjects. Neutrophil HLA-DR expression did not significantly differ between groups. Monocytes from septic shock patients had significantly less HLA-DR expression than normal subjects and there was a trend toward a lower proportion of gated monocytes that expressed CD14 in septic shock patients. Septic shock patients had no significant increases in IL-2R or HLA-DR expression on CD3 lymphocytes compared with control subjects, but they had significantly lower numbers of total, CD3, CD4, and CD8 lymphocytes and a higher prevalence of anergy. Septic shock patients manifested an increase in neutrophil CD11b expression that may play a role in organ injury. In contrast, a more specific decrease in monocyte expression of functional antigens is also observed in patients with septic shock that may have implications for immunologic defense mechanisms.
authors.affiliation: Department of Medicine, St. Vincent's Hospital and Medical Center of New York, New York Medical College.
authors.forename: R Y
authors.initials: RY
authors.lastname: Lin
authors.forename: M E
authors.initials: ME
authors.lastname: Astiz
authors.forename: J C
authors.initials: JC
authors.lastname: Saxon
authors.forename: E C
authors.initials: EC
authors.lastname: Rackow
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000032:analysis*; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis*; D018845:CD11 Antigens; D016516:CD4-CD8 Ratio; D006684:HLA-DR Antigens / Q000032:analysis*; D006801:Humans; D016130:Immunophenotyping; D007962:Leukocytes / Q000276:immunology*; D018950:Lipopolysaccharide Receptors; D008213:Lymphocyte Activation; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D012772:Shock, Septic / Q000276:immunology*
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D018845:CD11 Antigens; D006684:HLA-DR Antigens; D018950:Lipopolysaccharide Receptors; D015375:Receptors, Interleukin-2